Tilray CEO on first earnings document and rising cannabis trade

Tilray CEO on first earnings document and rising cannabis trade

Tilray CEO Brendan Kennedy discusses his company’s issue alongside the expansion of the medical pot trade as a total.

Tilray CEO on Canada legalization, express and the cannabis alternate

Tilray CEO on Canada legalization, express and the cannabis alternate

Tilray CEO Brendan Kennedy sits down with CNBC’s ‘Instruct on the Avenue’ crew to focus on the manner ahead for his company and the cannabis alternate after Canada legalized leisure…

Tilray CEO on shares being down, oversupply, U.S. cannabis legislation and Canada expansion plans

Tilray CEO on shares being down, oversupply, U.S. cannabis legislation and Canada expansion plans

Irwin Simon, Tilray CEO, joins ‘Closing Bell’ to chat regarding the firm’s shares being down over the closing 365 days and what headwinds the firm is facing.

Tilray CEO: Opportunities in scientific cannabis are gigantic

Tilray CEO: Opportunities in scientific cannabis are gigantic

Tilray’s stock is up as of late, nevertheless relax 80 p.c from a February high. CNBC’s Frank Holland stories on his dialog with Tilray CEO Irwin Simon in regards to…

Tilray CEO: There is a doubtless to grow the industry by infusing whiskey with cannabis

Tilray CEO: There is a doubtless to grow the industry by infusing whiskey with cannabis

Irwin Simon, Tilray CEO, joins ‘Closing Bell’ to command about its acquisition of Breckenridge distillery, and the possibility of infusing whiskey with cannabis. For catch entry to to stay and…

Tilray CEO Irwin Simon reacts to President Biden marijuana pardons

Tilray CEO Irwin Simon reacts to President Biden marijuana pardons

Irwin Simon, Tilray CEO, joins ‘Closing Bell’ to debate the importance of the White Condominium’s marijuana pardon files, what a schedule change would mean for marijuana in criminal law and…